1. LSD1 as a Biomarker and the Outcome of Its Inhibitors in the Clinical Trial: The Therapy Opportunity in Tumor
   Clement Agboyibor et al, 2021, Journal of Oncology CrossRef
2. The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response
   Eva De Smedt et al, 2018, Frontiers in Oncology CrossRef